Generation of a human iPSC line CIPi004-A from a patient with neurofibromatosis type 1 and epilepsy harboring a heterozygous mutation in NF1 gene

Stem Cell Res. 2024 Jun:77:103444. doi: 10.1016/j.scr.2024.103444. Epub 2024 May 15.

Abstract

The NF1 gene is related to neurofibromatosis type 1 (NF1), which is an autosomal dominant disorder associated with multisystem involvement and epilepsy susceptibility. A human induced pluripotent stem cell (iPSC) line was derived from a pediatric patient with NF1 and epilepsy, harboring a heterozygous NF1 gene mutation. The iPSC line exhibits high levels of pluripotency markers, maintains the NF1 gene mutation, and demonstrates the capacity to undergo differentiation potential in vitro into three germ layers. The iPSC line will serve as a valuable resource for investigating the underlying mechanisms and conducting drug screening related to NF1 and NF1-associated epilepsy.

Publication types

  • Case Reports

MeSH terms

  • Cell Differentiation
  • Cell Line
  • Epilepsy* / genetics
  • Epilepsy* / pathology
  • Genes, Neurofibromatosis 1
  • Heterozygote*
  • Humans
  • Induced Pluripotent Stem Cells* / metabolism
  • Induced Pluripotent Stem Cells* / pathology
  • Male
  • Mutation*
  • Neurofibromatosis 1* / genetics
  • Neurofibromatosis 1* / pathology
  • Neurofibromin 1 / genetics

Substances

  • Neurofibromin 1
  • NF1 protein, human